The stock market is up Friday, with the Dow Jones Industrial Average up 0.65%, the Nasdaq up 0.32% and the S&P 500 up 0.47%. The biggest winners today include a pharmaceutical company with strong clinical trial results and an investment firm getting rid of delinquent loans. The biggest loser is offering $100 million in senior notes to the public.
Here are Tuesday’s market winners and loser.
Biggest Winners
Shares of Sunesis Pharmaceuticals, Inc. (NASDAQ: SNSS) are up 31.82% to $3.48 on trading volume of 5.5 million shares. The company on Tuesday reported strong results for its Phase 3 trial vosaroxin, a drug intended for patients with lukemia. The 52-week high is $3.57.
Shares of MGIC Investment Corp. (NYSE: MTG) are up 10.25% to $1.78 on trading volume of 5.6 million shares. The firm announced it had ended primary deliquent inventory of 150,388 loans. The 52-week high is $5.15.
Biggest Loser
Shares of Sequenon Inc. (NASDAQ: SQNM) are down 9.91% to $3.52 on trading volume of 2.7 million. The company announced a proposed offering of $100 million of convertible senior notes. The 52-week low is $2.65.
Samuel Weigley
Follow him on Twitter: SWeigley
Want to Retire Early? Start Here (Sponsor)
Want retirement to come a few years earlier than you’d planned? Or are you ready to retire now, but want an extra set of eyes on your finances?
Now you can speak with up to 3 financial experts in your area for FREE. By simply clicking here you can begin to match with financial professionals who can help you build your plan to retire early. And the best part? The first conversation with them is free.
Click here to match with up to 3 financial pros who would be excited to help you make financial decisions.
Have questions about retirement or personal finance? Email us at [email protected]!
By emailing your questions to 24/7 Wall St., you agree to have them published anonymously on a673b.bigscoots-temp.com.
By submitting your story, you understand and agree that we may use your story, or versions of it, in all media and platforms, including via third parties.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
